Decision Diagnostics Corp. (DECN)

Market Cap	380.00 -99.0%
Revenue (ttm)	2.13M -3.1%
Net Income	-8.29M
EPS	-0.02
Shares Out	380.49M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,000
Average Volume	99,340
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0001
Beta	-0.04
RSI	48.15
Earnings Date	n/a

About Decision Diagnostics

Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It manufactures and distributes GenUltimate! glucose test strips, a Class II medical device for at-home use for the measurement of glucose; PetSure! glucose test strip for the glucose testing of d...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2000
• Employees: 8
• Stock Exchange: OTCMKTS
• Ticker Symbol: DECN

Financial Performance

In 2020, Decision Diagnostics's revenue was $1.98 million, a decrease of -16.82% compared to the previous year's $2.38 million. Losses were -$29.67 million, 847.2% more than in 2019.